NKCL project was introduced in the event
held on August 30 in Kuala Lumpur, Malaysia. A Malaysian news agency, BERNAMA and
major Chinese media like China Times has covered and broadcasted the event.
GK Global Group, parent company of NKCL Bio
Group, presented NKCL (Immune Care Platform) project in this event.
GK Global Group have also signed Memorandum
of Agreement with INIX from Malaysia and RLONG TUO International Watch from China,
establishing strategic business partnership to develop and operate its platform
in Chinese speaking countries.
Chairman of GK Global Group, Shin Dong Hwa,
CEO of INIX Network Chow Hung Keey and CEO of RLONG TUO International Watch,
Linda Chen have attended the ceremony. The three company has agreed to collaborate
and share their resources such as customer network, supply chain, facilities
and marketing strategy, etc. to build a stronger business platform.
Chairman of GK Global Group, Shin Dong Hwa
said, “This MOA has allowed us to gain a foothold for the project to expand in
Malaysia, Southeast Asia, and Great China Region. Over the next three years, we
will be creating an added value of $ 300 million to over $ 500 million in the
Greater China market alone.”